EU and South Africa conditionally clear GSK/Pfizer
The European Commission has ordered Pfizer to globally divest its ThermaCare brand to proceed with the company’s proposed €10.8 billion joint venture with GlaxoSmithKline, while South Africa’s enforcer also imposed remedies on the deal.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.